Bookshelf
| can't find it |

| browse books |
books
 

| book details |

The Global Crisis of Drug-Resistant Tuberculosis and Leadership of China and the Brics: Challenges and Opportunities: Summary of a Joint Workshop by the Institute of Medicine and the Institute of Microbiology, Chinese Academy of Sciences

By (author) Forum on Drug Discovery, Development, and Translation, By (author) Board on Health Sciences Policy, By (author) Institute of Medicine, Edited by Steve Olson, Edited by Rebecca A. English, Edited by Anne B. Claiborne





This book is currently unavailable. Enquire to check if we can source a used copy


| book description |

Multidrug-resistant tuberculosis (TB) is caused by bacteria resistant to isoniazid and rifampicin, the two most effective first-line anti-TB drugs, originally developed and introduced in the 1950 and 1960s. Since 2008, the Forum on Drug Discovery, Development, and Translation of the Institute of Medicine has hosted or co-hosted six domestic and international workshops addressing the global crisis of drug-resistant TB, with special attention to the BRICS countries - Brazil, Russia, India, China, and South Africa. The Global Crisis of Drug-Resistant Tuberculosis and Leadership of China and the BRICS is the summary of a workshop convened to address the current status of drug-resistant TB globally and in China. This report considers lessons learned from high burden countries; highlights global challenges to controlling the spread of drug-resistant strains; and discusses innovative strategies to advance and harmonize local and international efforts to prevent and treat drug-resistant TB. Additionally, the report examines the problem of MDR TB and emergent TB strains that are potentially untreatable with drugs available and considers the critical leadership role of the BRICS countries in addressing the threats and opportunities in drug-resistant TB.

| product details |



Normally shipped | Enquiries only
Publisher | National Academies Press
Published date | 28 Feb 2014
Language |
Format | Hardback
Pages | 218
Dimensions | 229 x 152 x 0mm (L x W x H)
Weight | 0g
ISBN | 978-0-3093-8770-5
Readership Age |
BISAC | medical / public health


| other options |


| your trolley |

To view the items in your trolley please sign in.

| sign in |

| specials |

The Silent Patient: The record-breaking, multimillion copy Sunday Times bestselling thriller and TikTok sensation

Alex Michaelides
Paperback / softback
352 pages
was: R 280.95
now: R 252.95
Available from overseas. Dispatched in aprox 4-8 weeks as local supplier is out of stock

With film rights snapped up by an Oscar winning Hollywood production company, rights sold in a world record 43 territories, and rave blurbs from David Baldacci, Lee Child and A.

The Thing at 52

Mr. Ross Montgomery
Hardback
40 pages
was: R 363.95
now: R 345.95
Usually dispatched in 3 to 4 weeks as supplier is out of stock

The Thing at 52 is a beautiful picture book about friendship, loneliness and learning how to say goodbye.

Free Your Mind: The new world of manipulation and how to resist it

Laura Dodsworth
Paperback / softback
384 pages
was: R 300.95
now: R 270.95
Available from overseas. Dispatched in aprox 4-8 weeks as local supplier is out of stock

The Instant Sunday Times Bestseller Learn how to recognise and resist the daily attempts to control and manipulate your mind.